Tumor apelin and obesity are associated with reduced neoadjuvant chemotherapy response in a cohort of breast cancer patients
Abstract Obesity is a known factor increasing the risk of developing breast cancer and reducing disease free survival. In addition to these well-documented effects, recent studies have shown that obesity is also affecting response to chemotherapy. Among the multiple dysregulations associated with ob...
Guardado en:
Autores principales: | Florian Gourgue, Françoise Derouane, Cedric van Marcke, Elodie Villar, Helene Dano, Lieven Desmet, Caroline Bouzin, Francois P. Duhoux, Patrice D. Cani, Bénédicte F. Jordan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/582848c913f2403492804f339a90a0ea |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
por: Willard Wong, et al.
Publicado: (2021) -
The role of serum apelin in retinopathy of prematurity
por: Ali YF, et al.
Publicado: (2017) -
The Role of Apelin in the Functioning of the Reproductive System
por: A. O. Shpakov, et al.
Publicado: (2019) -
Neoadjuvant chemotherapy for advanced stage endometrial cancer: A systematic review
por: Allan B. Huang, et al.
Publicado: (2021) -
Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors
por: Ben‐Yuan Jiang, et al.
Publicado: (2021)